Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain.

Peptidic oligomers that contain both α- and β-amino acid residues, in regular patterns throughout the backbone, are emerging as structural mimics of α-helix-forming conventional peptides (composed exclusively of α-amino acid residues). Here we describe a comprehensive evaluation of diverse α/β-peptide homologues of the Bim BH3 domain in terms of their ability to bind to the BH3-recognition sites on two partner proteins, Bcl-x(L) and Mcl-1. These proteins are members of the anti-apoptotic Bcl-2 family, and both bind tightly to the Bim BH3 domain itself. All α/β-peptide homologues retain the side-chain sequence of the Bim BH3 domain, but each homologue contains periodic α-residue → β(3)-residue substitutions. Previous work has shown that the ααβαααβ pattern, which aligns the β(3)-residues in a 'stripe' along one side of the helix, can support functional α-helix mimicry, and the results reported here strengthen this conclusion. The present study provides the first evaluation of functional mimicry by ααβ and αααβ patterns, which cause the β(3)-residues to spiral around the helix periphery. We find that the αααβ pattern can support effective mimicry of the Bim BH3 domain, as manifested by the crystal structure of an α/β-peptide bound to Bcl-x(L), affinity for a variety of Bcl-2 family proteins, and induction of apoptotic signaling in mouse embryonic fibroblast extracts. The best αααβ homologue shows substantial protection from proteolytic degradation relative to the Bim BH3 α-peptide.

[1]  S. Gellman,et al.  Broad distribution of energetically important contacts across an extended protein interface. , 2011, Journal of the American Chemical Society.

[2]  Michael S. Kay,et al.  Inhibiting HIV Fusion with a β-Peptide Foldamer , 2005 .

[3]  J. Sodroski,et al.  Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic , 2010, Proceedings of the National Academy of Sciences.

[4]  Brooke N. Bullock,et al.  Mini review: protein-protein interactions in transcription: a fertile ground for helix mimetics. , 2011, Biopolymers.

[5]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Rotation Functions Biological Crystallography Likelihood-enhanced Fast Rotation Functions , 2003 .

[6]  C. Schafmeister,et al.  Shape-programmable macromolecules. , 2008, Accounts of chemical research.

[7]  S. Armstrong,et al.  Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members. , 2006, Cancer cell.

[8]  Chinmay Y. Majmudar,et al.  Amphipathic small molecules mimic the binding mode and function of endogenous transcription factors. , 2009, ACS chemical biology.

[9]  Randy J. Read,et al.  Pushing the boundaries of molecular replacement with maximum likelihood. , 2001, Acta crystallographica. Section D, Biological crystallography.

[10]  C. Thompson,et al.  Bcl-2-family proteins: the role of the BH3 domain in apoptosis. , 1998, Trends in cell biology.

[11]  P. V. von Hippel,et al.  Calculation of protein extinction coefficients from amino acid sequence data. , 1989, Analytical biochemistry.

[12]  P. Perlmutter,et al.  β-amino acids: Versatile peptidomimetics , 2002 .

[13]  Erinna F. Lee,et al.  Conformational Changes in Bcl-2 Pro-survival Proteins Determine Their Capacity to Bind Ligands* , 2009, The Journal of Biological Chemistry.

[14]  Lun K Tsou,et al.  Synthetic non-peptide mimetics of alpha-helices. , 2007, Chemical Society reviews.

[15]  P. Arora,et al.  Inhibition of HIV-1 fusion by hydrogen-bond-surrogate-based alpha helices. , 2008, Angewandte Chemie.

[16]  Hong-Gang Wang,et al.  Bcl-XL-templated assembly of its own protein-protein interaction modulator from fragments decorated with thio acids and sulfonyl azides. , 2008, Journal of the American Chemical Society.

[17]  Paramjit S Arora,et al.  Assessment of helical interfaces in protein-protein interactions. , 2009, Molecular bioSystems.

[18]  W Seth Horne,et al.  Helix bundle quaternary structure from alpha/beta-peptide foldamers. , 2007, Journal of the American Chemical Society.

[19]  Emiko Fire,et al.  The MCL-1 BH3 Helix is an Exclusive MCL-1 inhibitor and Apoptosis Sensitizer , 2010, Nature chemical biology.

[20]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[21]  L. Vassilev,et al.  In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2 , 2004, Science.

[22]  S. Warriner,et al.  N-alkylated oligoamide alpha-helical proteomimetics. , 2010, Organic & biomolecular chemistry.

[23]  Saul H Rosenberg,et al.  Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins. , 2008, Journal of medicinal chemistry.

[24]  Erinna F. Lee,et al.  A novel BH3 ligand that selectively targets Mcl-1 reveals that apoptosis can proceed without Mcl-1 degradation , 2008, The Journal of cell biology.

[25]  Michelle R. Arkin,et al.  Binding of small molecules to an adaptive protein–protein interface , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Toshiaki Hara,et al.  N-acylpolyamine inhibitors of HDM2 and HDMX binding to p53. , 2009, Bioorganic & medicinal chemistry.

[27]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[28]  M. Hinds,et al.  Structural plasticity underpins promiscuous binding of the prosurvival protein A1. , 2008, Structure.

[29]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[30]  Scott J. Shandler,et al.  Foldamers as versatile frameworks for the design and evolution of function. , 2007, Nature chemical biology.

[31]  Brian J. Smith,et al.  Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. , 2005, Molecular cell.

[32]  S. Sebti,et al.  Terephthalamide derivatives as mimetics of helical peptides: disruption of the Bcl-x(L)/Bak interaction. , 2005, Journal of the American Chemical Society.

[33]  Su Qiu,et al.  Structure-based design of spiro-oxindoles as potent, specific small-molecule inhibitors of the MDM2-p53 interaction. , 2006, Journal of medicinal chemistry.

[34]  Jorge Becerril,et al.  Design and application of an alpha-helix-mimetic scaffold based on an oligoamide-foldamer strategy: antagonism of the Bak BH3/Bcl-xL complex. , 2003, Angewandte Chemie.

[35]  S. Gellman,et al.  Hydrophile scanning as a complement to alanine scanning for exploring and manipulating protein–protein recognition: Application to the Bim BH3 domain , 2008, Protein science : a publication of the Protein Society.

[36]  Indraneel Ghosh,et al.  High Specificity in Protein Recognition by Hydrogen‐Bond‐Surrogate α‐Helices: Selective Inhibition of the p53/MDM2 Complex , 2010, Chembiochem : a European journal of chemical biology.

[37]  Joshua A. Kritzer,et al.  A Rapid Library Screen for Tailoring β-Peptide Structure and Function , 2005 .

[38]  W Seth Horne,et al.  Sequence-based design of alpha/beta-peptide foldamers that mimic BH3 domains. , 2008, Angewandte Chemie.

[39]  S. Gellman,et al.  Interplay among side chain sequence, backbone composition, and residue rigidification in polypeptide folding and assembly , 2008, Proceedings of the National Academy of Sciences.

[40]  E. J. Thomas,et al.  Stereoselective synthesis of Z-alkenes from α-methylcrotylstannanes and aldehydes , 1987 .

[41]  A. Petros,et al.  Rationale for Bcl‐XL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies , 2000, Protein science : a publication of the Protein Society.

[42]  W. Im,et al.  Novel pyrrolopyrimidine-based α-helix mimetics: cell-permeable inhibitors of protein−protein interactions. , 2011, Journal of the American Chemical Society.

[43]  Andrew D. Hamilton,et al.  Terphenyl-Based Bak BH3 α-Helical Proteomimetics as Low-Molecular-Weight Antagonists of Bcl-xL , 2005 .

[44]  Andrew D. Hamilton,et al.  Development of a Potent Bcl-xL Antagonist Based on α-Helix Mimicry , 2002 .

[45]  A. Hamilton,et al.  Strategies for targeting protein-protein interactions with synthetic agents. , 2005, Angewandte Chemie.

[46]  Paramjit S Arora,et al.  Systematic analysis of helical protein interfaces reveals targets for synthetic inhibitors. , 2010, ACS chemical biology.

[47]  Lin Chen,et al.  Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins. , 2005, Genes & development.

[48]  Erinna F. Lee,et al.  Structural insights into the degradation of Mcl-1 induced by BH3 domains , 2007, Proceedings of the National Academy of Sciences.

[49]  P. Colman,et al.  BCL-2 family antagonists for cancer therapy , 2008, Nature Reviews Drug Discovery.

[50]  Sukwon Hong,et al.  Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions. , 2009, Journal of the American Chemical Society.

[51]  P. Marrack,et al.  The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. , 2003, Immunity.

[52]  H. Hauser,et al.  β‐Peptides as Inhibitors of Small‐Intestinal Cholesterol and Fat Absorption , 1999 .

[53]  Erinna F. Lee,et al.  High-resolution structural characterization of a helical alpha/beta-peptide foldamer bound to the anti-apoptotic protein Bcl-xL. , 2009, Angewandte Chemie.

[54]  Structural Basis of Bcl‐xL Recognition by a BH3‐Mimetic α/β‐Peptide Generated by Sequence‐Based Design , 2011, Chembiochem : a European journal of chemical biology.

[55]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[56]  S. Korsmeyer,et al.  Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix , 2004, Science.

[57]  Min Lu,et al.  Structural and biological mimicry of protein surface recognition by α/β-peptide foldamers , 2009, Proceedings of the National Academy of Sciences.

[58]  Samuel H. Gellman,et al.  Rational Development of β-Peptide Inhibitors of Human Cytomegalovirus Entry* , 2006, Journal of Biological Chemistry.

[59]  P. Arora,et al.  Enhanced metabolic stability and protein-binding properties of artificial alpha helices derived from a hydrogen-bond surrogate: application to Bcl-xL. , 2005, Angewandte Chemie.

[60]  David C Fry,et al.  Protein-protein interactions as targets for small molecule drug discovery. , 2006, Biopolymers.

[61]  S. Gellman,et al.  Structural consequences of beta-amino acid preorganization in a self-assembling alpha/beta-peptide: fundamental studies of foldameric helix bundles. , 2010, Journal of the American Chemical Society.

[62]  Toshiaki Hara,et al.  Probing the structural requirements of peptoids that inhibit HDM2-p53 interactions. , 2006, Journal of the American Chemical Society.

[63]  Brooke N. Bullock,et al.  Assessing helical protein interfaces for inhibitor design. , 2011, Journal of the American Chemical Society.

[64]  Raymond E. Moellering,et al.  Direct inhibition of the NOTCH transcription factor complex , 2009, Nature.

[65]  Chengyu Liang,et al.  Evidence that inhibition of BAX activation by BCL-2 involves its tight and preferential interaction with the BH3 domain of BAX , 2011, Cell Research.

[66]  P. S. Kim,et al.  A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants. , 1993, Science.

[67]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Likelihood-enhanced Fast Translation Functions Biological Crystallography Likelihood-enhanced Fast Translation Functions , 2022 .

[68]  Shibo Jiang,et al.  Design of a protein surface antagonist based on alpha-helix mimicry: inhibition of gp41 assembly and viral fusion. , 2002, Angewandte Chemie.

[69]  S. Gellman,et al.  An alpha/beta-peptide helix bundle with a pure beta3-amino acid core and a distinctive quaternary structure. , 2009, Journal of the American Chemical Society.